The single cell analysis market is expected to grow worldwide at a CAGR of 19.72% between the forecast periods of 2017-2025. The main driving factor for this expected growth is the increased technological advancement in single cell analysis products in the recent years, the increasing number of biopharmaceutical and biotechnological companies and the increasing prevalence of infectious diseases globally.
The single cell analysis market is mainly divided into two aspects of research application and medical application. The research applications consists of various aspects like cancer market, immunology market, neurology market, and the stem cells market along with various other research application of single cell analysis in areas like developmental biology, metagenomics, drug discovery, plant biology, microbial ecology, evolution, forensics, and allele-specific gene expression and hence has an upper hand over the medical application market which is divided between circular tumor cells (CTCS) market, non-invasive prenatal diagnosis market, and in-vitro fertilization (IVF) market. In terms of techniques, micro array is currently the fastest growing market with an expected CAGR of 20.20%. With respect to the cell type the human cells market holds the largest market share in the global single cell analysis market as compared to the animal cell market. Also, thec consumables products are fast becoming the current market leaders with the fastest growing market with products like assay kits, beads, micro plates, reagents etc
The increasing applications of single-cell analysis in cancer research in the Northern America due to advanced technology, booming biotechnology and biopharmaceutical industries and rising prevalence of infectious diseases is estimated to get it the maximum share in the single cell market by the year 2025 closely followed by Asia-Pacific which is growing considerably fast owning to the need for stem cell therapies and a rise in lifestyle oriented diseases in the region.
The major companies competing in the single cell analysis market are Beckton Dickinson, Miltenyi Biotec, Corning Inc, Nanostring technologies Inc, Celgene corporation, Agilent technology Inc, Medtronic’s, Qiagen, GE healthcare and Stryker corporation out of which GE Healthcare has the largest market share followed by Stem cell technologies.